Примери за използване на Serum potassium на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Hyperkalaemia(serum potassium> 5.5 mmol/ l)
Close monitoring of serum potassium in patients at risk is recommended(see section 4.5).
If serum potassium falls below the desired range,
In patients with uncorrected hypokalaemia(serum potassium of less than 3.5 mmol/l), potassium levels should be corrected prior to use of vernakalant.
If co-medication with an agent affecting the level of serum potassium is considered necessary, caution is advisable.
In Part B, serum potassium in patients on placebo increased significantly relative to patients who remained on patiromer(p< 0.001).
There is a reduction in urinary potassium excretion which is a consequence of a reduction in serum potassium concentration.
aldosterone secretion resulting in a decrease in serum potassium.
Serum potassium at the end of treatment,
increase the level of serum potassium.
Serum potassium should be monitored periodically
creatine kinase Decreases in serum potassium and sodium.
These medicinal products may potentiate the effect of hydrochlorothiazide on serum potassium(see section 4.4).
Potassium-sparing diuretics should be used with caution in patients receiving ACE inhibitors, and serum potassium and renal function should be monitored.
Treatment should not be initiated if the serum potassium level is> 5.4 mmol/l.
If serum potassium level is> 5.4 mmol/l discontinuation should be considered.
Treatment should not be initiated in patients with serum potassium level> 5.4 mmol/l or with SBP< 100 mmHg(see section 4.4).
Clinical laboratory results indicated decreases in serum potassium after topiramate or HCTZ administration,
Serum potassium and phosphate levels should be monitored regularly during NeoRecormon therapy.